Literature DB >> 9708787

Drug approval in Japan questioned.

K Hayashi, K Hashimoto, M Yanagi, T Umeda, R Hama.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9708787     DOI： 10.1016/S0140-6736(05)79232-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

Review 1.  Clinical trials and the new good clinical practice guideline in Japan. An economic perspective.

Authors:  S Ono; Y Kodama
Journal:  Pharmacoeconomics       Date:  2000-08       Impact factor: 4.981

2.  The effect size, study design, and development experience in commercially sponsored studies for new drug applications in approved drugs.

Authors:  Satoshi Fukunaga; Makiko Kusama; Shunsuke Ono
Journal:  Springerplus       Date:  2014-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.